Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Blood Transfusion = Trasfusione Del Sangue|February 4, 2021
Thrombophilia testing in the real-world clinical setting of thrombosis centres taking part in the Italian Start 2-RegisterCristina Legnani, Gualtiero Palareti, Emilia Antonucci, et al.
Thrombosis and Haemostasis|January 12, 2013
The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbsBenilde Cosmi, Cristina Legnani, Vittorio Pengo, et al.
Thrombosis Research|April 26, 2024
D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical resultsGualtiero Palareti, Cristina Legnani, Alberto Tosetto, et al.
British Journal of Haematology|April 2, 2005
Risks factors for highly unstable response to oral anticoagulation: a case-control studyGualtiero Palareti, Cristina Legnani, Giuliana Guazzaloca, et al.
Clinical Chemistry and Laboratory Medicine|August 26, 2014
How the direct oral anticoagulant apixaban affects hemostatic parameters. Results of a multicenter multiplatform studyArmando Tripodi, Lidia Padovan, Sophie Testa, et al.
Thrombosis Research|June 2, 2009
Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: a prospective, randomised study comparing two doses of parnaparin (BAFLUX study)Davide Imberti, Cristina Legnani, Edoardo Baldini, et al.
Thrombosis and Haemostasis|August 10, 2010
Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO studyGualtiero Palareti, Benilde Cosmi, Gianfranco Lessiani, et al.
Journal of Thrombosis and Thrombolysis|March 17, 2009
Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG studyBenilde Cosmi, Cristina Legnani, Alberto Tosetto, et al.
Thrombosis Research|December 25, 2013
Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum)Benilde Cosmi, Massimo Filippini, Fausto Campana, et al.
Thrombosis and Haemostasis|March 31, 2010
Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG studyBenilde Cosmi, Cristina Legnani, Alberto Tosetto, et al.
Pageof 10